Epilepsy trials in Netherlands

In Netherlands 14 Also abroad 452

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
OV329 Evaluation in Participants with Epilepsy and PPR
Where
Leiden
Age
18 years and over
People
4
Run by
Ovid Therapeutics Inc.
See details and how to join2026-527114-23-00 · EU 2026-527114-23-00
Phase 3Taking people
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Where
Heeze
Age
12 years and over
People
160 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00
Phase 3Taking people
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Where
Heeze
Age
18 years and over
People
360 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00
Phase 3Enrolling by invitation
An Open-label Study of XEN1101 in Epilepsy
Where
Heeze
Age
12 years and over
People
880 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00
No phaseTaking people
Multi-biomarkers in DEE
Where
Amsterdam
Age
0 years to 55 years
People
200 worldwide
Run by
Istituto Giannina Gaslini
See details and how to joinNCT07909382
Phase 3Enrolling by invitation
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Where
Utrecht
Age
2 years to 66 years
People
324 worldwide
Run by
Longboard Pharmaceuticals
See details and how to joinNCT06908226 · EU 2024-514974-39-00
No phaseTaking people
Prospective Natural History Study of POLG Disease
Where
Maastricht
People
300 worldwide
Run by
The POLG Foundation
See details and how to joinNCT07775872
Phase 1Taking people
Three-part PK and PD study of AXN-027
Where
Leiden
Age
18 years to 64 years
People
64
Run by
Axonis Therapeutics Inc.
See details and how to join2025-524019-35-00 · EU 2025-524019-35-00
Phase 2Not yet taking people in Netherlands
A Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Potential Antiseizure Activity of Adjunctive OV329 Therapy in Adults with Drug-Resistant Focal Epilepsy
Where
Maastricht
Age
18 years and over
People
6
Run by
Ovid Therapeutics Inc.
See details and how to join2026-525896-23-00 · EU 2026-525896-23-00
Phase 3Taking people
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
Where
Utrecht
Age
1 year to 18 years
People
50
Run by
UMC Utrecht
See details and how to joinNCT07668856
Phase 2Enrolling by invitation
Long-term Safety and Tolerability of BHV-7000
Where
Heemstede, Heeze, Zwolle
Age
18 years to 75 years
People
660 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00
Phase 3Taking people
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach
Where
Heemstede, Heeze, Maastricht, Rotterdam, Utrecht
Age
Up to 17 years
People
50
Run by
Universitair Medisch Centrum Utrecht
See details and how to join2023-507843-12-01 · EU 2023-507843-12-01
No phaseTaking people
Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid )
Where
Utrecht
Age
18 years and over
People
12
Run by
Neurosoft Bioelectronics SA
See details and how to joinNCT06205160
No phaseTaking people
REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
Where
Heeze
Age
18 years and over
People
200 worldwide
Run by
Aziende Chimiche Riunite Angelini Francesco S.p.A
See details and how to joinNCT06922175